Stay updated on AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial

Sign up to get notified when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The temporary banner announcing NIH terminology changes and linking to transition updates and FAQs was removed.
    Difference
    1%
    Check dated 2026-11-08T04:30:54.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-11-01T01:51:29.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T01:53:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:39:19.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:12:43.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, indicating that access to the page is blocked. The layout mirrors a standard error page with a 403 message and site header/footer.
    Difference
    21%
    Check dated 2026-09-20T01:05:29.000Z thumbnail image

Stay in the know with updates to AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AFM24/SNK01 Combo in EGFR+ Cancers Clinical Trial page.